Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Breast cancer and Cancer research, with related work in Long non-coding RNA, Carcinogenesis, DNA methylation. Notable publications include 'PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer', 'Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer', and 'Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer'.
RNA atlas and competing endogenous RNA regulation in tissue-derived exosomes from luminal B and triple-negative breast cancer patients
Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
LncRNA TINCR favors tumorigenesis via STAT3–TINCR–EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer
Expression and prognostic values of ARID family members in breast cancer
Silencing of PGK1 Promotes Sensitivity to Paclitaxel Treatment by Upregulating XAF1-Mediated Apoptosis in Triple-Negative Breast Cancer
Long noncoding RNA <i>PVT1</i> acts as an oncogenic driver in human pan‐cancer
Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer
Long noncoding RNA <i>FER1L4</i> acts as an oncogenic driver in human pan‐cancer
Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer
PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer
The long non-coding RNA <i>EPB41L4A-AS2</i> inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors
A High-Quality Biobank Supports Breast Cancer Research in Harbin, China
Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.
PubMed 2015cited by 151position: middle
Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer